Clearstead Advisors’s Core Laboratories CLB Stock Holding History

Clearstead Advisors’s Portfolio CLB Stock Details CLB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$222	Buy	+19	New	+$271	﹤0.01%	3182
2025 Q3	–	Sell	-6,504	Closed	-$74.9K	–	3122
2025 Q2	$74.9K	Hold	6,504	–	–	﹤0.01%	1154
2025 Q1	$97.5K	Hold	6,504	–	–	﹤0.01%	1005
2024 Q4	$113K	Hold	6,504	–	–	﹤0.01%	994
2024 Q3	$121K	Buy	6,504 +278	+4%	+$5.58K	﹤0.01%	982
2024 Q2	$126K	Buy	6,226 +6,124	+6,004%	+$108K	﹤0.01%	948
2024 Q1	$1.77K	Hold	102	–	–	﹤0.01%	1328
2023 Q4	$1.8K	Hold	102	–	–	﹤0.01%	1298
2023 Q3	$2.45K	Buy	+102	New	+$2.5K	﹤0.01%	1206
2021 Q2	–	Sell	-25	Closed	-$1K	–	1265
2021 Q1	$1K	Hold	25	–	–	﹤0.01%	1009
2020 Q4	$1K	Hold	25	–	–	﹤0.01%	919
2020 Q3	$0	Buy	+25	New	+$524	﹤0.01%	891

Other funds holding CLB

Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

DGI

Disciplined Growth Investors Minneapolis, Minnesota $5.91B AUM 53.97% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

CAMG

CWA Asset Management Group Naples, Florida $3.28B AUM 34.07% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Schroder Investment Management Group London, United Kingdom $141B AUM 34.18% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Clearstead Advisors's CLB Position: Q2 2026 in Review

Clearstead Advisors opened a new position in Core Laboratories (CLB) in Q2 2026: 19 shares worth $222. The stake represents ﹤0.01% of the portfolio and ranks #3182 among its holdings. This is a return to the name: Clearstead Advisors previously reported a position in CLB as recently as Q2 2025.

Clearstead Advisors first reported a position in CLB in Q3 2020 and has held it in 12 quarters since. The position peaked at $126K in Q2 2024. 186 funds tracked by Wall St. Rank hold CLB as of Q2 2026.

Clearstead Advisors held 19 shares of Core Laboratories worth $222 as of Q2 2026.
Core Laboratories was a new Clearstead Advisors position in Q2 2026.
Core Laboratories made up ﹤0.01% of Clearstead Advisors's portfolio in Q2 2026, its #3182 holding.
Clearstead Advisors first reported a position in Core Laboratories in Q3 2020 and has held it in 12 quarters since.
Clearstead Advisors's Core Laboratories position peaked at $126K in Q2 2024.
186 funds tracked by Wall St. Rank held Core Laboratories as of Q2 2026.

Based on Clearstead Advisors's 13F filing for Q2 2026, filed 6 Aug 2026.